Logo image of TGEN

TECOGEN INC/WALTHAM MA (TGEN) Stock Fundamental Analysis

USA - NYSE Arca - NYSEARCA:TGEN - US87876P2011 - Common Stock

5.09 USD
+0.1 (+2%)
Last: 1/16/2026, 8:04:00 PM
5.1 USD
+0.01 (+0.2%)
After Hours: 1/16/2026, 8:04:00 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to TGEN. TGEN was compared to 42 industry peers in the Building Products industry. While TGEN seems to be doing ok healthwise, there are quite some concerns on its profitability. TGEN is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • In the past year TGEN has reported negative net income.
  • In the past year TGEN had a positive cash flow from operations.
  • In the past 5 years TGEN reported 4 times negative net income.
  • In multiple years TGEN reported negative operating cash flow during the last 5 years.
TGEN Yearly Net Income VS EBIT VS OCF VS FCFTGEN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M -4M -6M

1.2 Ratios

  • TGEN has a Return On Assets of -15.31%. This is amonst the worse of the industry: TGEN underperforms 85.71% of its industry peers.
  • Looking at the Return On Equity, with a value of -46.53%, TGEN is doing worse than 88.10% of the companies in the same industry.
Industry RankSector Rank
ROA -15.31%
ROE -46.53%
ROIC N/A
ROA(3y)-13.51%
ROA(5y)-9.91%
ROE(3y)-30.18%
ROE(5y)-21.73%
ROIC(3y)N/A
ROIC(5y)N/A
TGEN Yearly ROA, ROE, ROICTGEN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40

1.3 Margins

  • TGEN has a Gross Margin of 43.64%. This is amongst the best in the industry. TGEN outperforms 85.71% of its industry peers.
  • In the last couple of years the Gross Margin of TGEN has grown nicely.
  • The Profit Margin and Operating Margin are not available for TGEN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 43.64%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.79%
GM growth 5Y3.17%
TGEN Yearly Profit, Operating, Gross MarginsTGEN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

4

2. Health

2.1 Basic Checks

  • TGEN does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • TGEN has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, TGEN has more shares outstanding
  • The debt/assets ratio for TGEN is higher compared to a year ago.
TGEN Yearly Shares OutstandingTGEN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
TGEN Yearly Total Debt VS Total AssetsTGEN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

  • An Altman-Z score of 2.70 indicates that TGEN is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 2.70, TGEN is doing worse than 64.29% of the companies in the same industry.
  • The Debt to FCF ratio of TGEN is 0.63, which is an excellent value as it means it would take TGEN, only 0.63 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 0.63, TGEN belongs to the top of the industry, outperforming 88.10% of the companies in the same industry.
  • A Debt/Equity ratio of 0.18 indicates that TGEN is not too dependend on debt financing.
  • TGEN's Debt to Equity ratio of 0.18 is fine compared to the rest of the industry. TGEN outperforms 69.05% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 0.63
Altman-Z 2.7
ROIC/WACCN/A
WACC9.84%
TGEN Yearly LT Debt VS Equity VS FCFTGEN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

2.3 Liquidity

  • A Current Ratio of 1.32 indicates that TGEN should not have too much problems paying its short term obligations.
  • The Current ratio of TGEN (1.32) is worse than 80.95% of its industry peers.
  • TGEN has a Quick Ratio of 1.32. This is a bad value and indicates that TGEN is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Quick ratio value of 0.74, TGEN is not doing good in the industry: 90.48% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.32
Quick Ratio 0.74
TGEN Yearly Current Assets VS Current LiabilitesTGEN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

4

3. Growth

3.1 Past

  • TGEN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -220.48%.
  • TGEN shows a small growth in Revenue. In the last year, the Revenue has grown by 2.46%.
  • TGEN shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -5.52% yearly.
EPS 1Y (TTM)-220.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)2.46%
Revenue growth 3Y-9.23%
Revenue growth 5Y-5.52%
Sales Q2Q%27.58%

3.2 Future

  • Based on estimates for the next years, TGEN will show a very strong growth in Earnings Per Share. The EPS will grow by 38.30% on average per year.
  • The Revenue is expected to grow by 22.20% on average over the next years. This is a very strong growth
EPS Next Y-53%
EPS Next 2Y-23.69%
EPS Next 3Y-38.42%
EPS Next 5Y38.3%
Revenue Next Year-2.95%
Revenue Next 2Y8.41%
Revenue Next 3Y1.41%
Revenue Next 5Y22.2%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
TGEN Yearly Revenue VS EstimatesTGEN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 20M 40M 60M 80M 100M
TGEN Yearly EPS VS EstimatesTGEN Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.2 -0.2 0.4 0.6

0

4. Valuation

4.1 Price/Earnings Ratio

  • TGEN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for TGEN. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TGEN Price Earnings VS Forward Price EarningsTGEN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

  • Based on the Price/Free Cash Flow ratio, TGEN is valued a bit more expensive than the industry average as 64.29% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 49.15
EV/EBITDA N/A
TGEN Per share dataTGEN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6

4.3 Compensation for Growth

  • A cheap valuation may be justified as TGEN's earnings are expected to decrease with -38.42% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-23.69%
EPS Next 3Y-38.42%

0

5. Dividend

5.1 Amount

  • No dividends for TGEN!.
Industry RankSector Rank
Dividend Yield 0%

TECOGEN INC/WALTHAM MA

NYSEARCA:TGEN (1/16/2026, 8:04:00 PM)

After market: 5.1 +0.01 (+0.2%)

5.09

+0.1 (+2%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)11-12
Earnings (Next)03-16
Inst Owners29.01%
Inst Owner Change-0.03%
Ins Owners22.95%
Ins Owner Change1.23%
Market Cap151.94M
Revenue(TTM)25.00M
Net Income(TTM)-4.76M
Analysts82.86
Price Target15.3 (200.59%)
Short Float %10.17%
Short Ratio2.7
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-31.96%
Min Revenue beat(2)-33.4%
Max Revenue beat(2)-30.52%
Revenue beat(4)0
Avg Revenue beat(4)-30.88%
Min Revenue beat(4)-39.65%
Max Revenue beat(4)-19.94%
Revenue beat(8)2
Avg Revenue beat(8)-17.83%
Revenue beat(12)3
Avg Revenue beat(12)-15.77%
Revenue beat(16)4
Avg Revenue beat(16)-15.85%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-52.94%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 6.72
P/FCF 49.15
P/OCF 37.42
P/B 14.85
P/tB 28.29
EV/EBITDA N/A
EPS(TTM)-0.1
EYN/A
EPS(NY)-0.15
Fwd EYN/A
FCF(TTM)0.1
FCFY2.03%
OCF(TTM)0.14
OCFY2.67%
SpS0.76
BVpS0.34
TBVpS0.18
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -15.31%
ROE -46.53%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 43.64%
FCFM 13.67%
ROA(3y)-13.51%
ROA(5y)-9.91%
ROE(3y)-30.18%
ROE(5y)-21.73%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.79%
GM growth 5Y3.17%
F-Score4
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 0.63
Debt/EBITDA N/A
Cap/Depr 175.01%
Cap/Sales 4.28%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.32
Quick Ratio 0.74
Altman-Z 2.7
F-Score4
WACC9.84%
ROIC/WACCN/A
Cap/Depr(3y)87.45%
Cap/Depr(5y)67.63%
Cap/Sales(3y)1.94%
Cap/Sales(5y)1.42%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-220.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y-53%
EPS Next 2Y-23.69%
EPS Next 3Y-38.42%
EPS Next 5Y38.3%
Revenue 1Y (TTM)2.46%
Revenue growth 3Y-9.23%
Revenue growth 5Y-5.52%
Sales Q2Q%27.58%
Revenue Next Year-2.95%
Revenue Next 2Y8.41%
Revenue Next 3Y1.41%
Revenue Next 5Y22.2%
EBIT growth 1Y2.75%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year3.59%
EBIT Next 3Y70.17%
EBIT Next 5YN/A
FCF growth 1Y457.51%
FCF growth 3Y112.98%
FCF growth 5YN/A
OCF growth 1Y596.53%
OCF growth 3Y105.19%
OCF growth 5YN/A

TECOGEN INC/WALTHAM MA / TGEN FAQ

What is the fundamental rating for TGEN stock?

ChartMill assigns a fundamental rating of 3 / 10 to TGEN.


What is the valuation status of TECOGEN INC/WALTHAM MA (TGEN) stock?

ChartMill assigns a valuation rating of 0 / 10 to TECOGEN INC/WALTHAM MA (TGEN). This can be considered as Overvalued.


What is the profitability of TGEN stock?

TECOGEN INC/WALTHAM MA (TGEN) has a profitability rating of 2 / 10.


Can you provide the expected EPS growth for TGEN stock?

The Earnings per Share (EPS) of TECOGEN INC/WALTHAM MA (TGEN) is expected to decline by -53% in the next year.